Vascular Grafts Market Size 2024-2028 

The vascular grafts market size is forecast to increase by USD 1.52 billion and is estimated to grow at a CAGR of 7.08% between 2023 and 2028. In recent years, the healthcare industry in Asia has witnessed significant advancements, particularly in the realm of technologically-advanced products and services. This technological revolution has led to an increase in the number of Ambulatory Surgery Centers (ASCs) across the region, offering more convenient and cost-effective healthcare solutions for patients. Medical tourism in Asia is also on the rise, attracting patients from around the world due to the high-quality, affordable care provided by advanced medical facilities. The introduction of innovative medical technologies, coupled with the growing number of ASCs and medical tourism destinations, positions Asia as a global leader in healthcare innovation and accessibility.

What will be the Size of the Market During the Forecast Period?

For More Highlights About this Report, Request Free Sample

Market Dynamic and Customer Landscape

The market refers to the production and sale of artificial blood vessels used to replace damaged or diseased arteries. These grafts are essential in addressing various vascular conditions such as abdominal aneurysms and peripheral artery diseases. The market is driven by factors like the geriatric population, smoking, and the increasing prevalence of chronic diseases like diabetes and heart attacks. Raw materials used in manufacturing vascular grafts include polytetrafluoroethylene (PTFE) and expanded polytetrafluoroethylene (ePTFE). Surgical procedures like hemodialysis vascular access and coronary artery bypass grafting (CABG) utilize vascular grafts. Vascular obstacles like intimal hyperplasia and thrombosis necessitate the use of these grafts. Government funding and healthcare expenditure contribute to market growth, particularly in emerging economies. The ongoing COVID-19 pandemic has impacted the market due to disrupted healthcare systems and supply chains. Minimally invasive procedures, such as the MIDCAB procedure, are gaining popularity due to their constructive graft remodeling capabilities and reduced recovery time. The market is expected to witness significant growth due to the increasing burden of chronic diseases and the rising demand for minimally invasive surgical procedures. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

Introduction of technologically advanced products is notably driving market growth. Over the past decade, advancements in surgical techniques have led to the emergence of minimally invasive procedures, such as off-pump coronary artery bypass (MIDCAB), which allows skilled surgeons to perform most coronary artery bypass grafting (CABG) procedures without the use of cardiopulmonary bypass.

Moreover, this approach has resulted in decreased postoperative blood loss and transfusion, making it particularly beneficial for high-risk patient groups, such as those with aortic atheroma, cirrhosis, or renal insufficiency. Moreover, patients' increasing preference for minimally invasive procedures and smaller incisions has led to the development of techniques that avoid sternotomy, such as the MIDCAB procedure. Thus, such factors are driving the growth of the market during the forecast period.

Significant Market Trends

Emergence of next-generation TEVGs is the key trend in the market. Cardiovascular diseases (CVDs) remain a leading cause of global mortality, primarily due to conditions such as stenosis or occlusion of blood vessels. These conditions necessitate vascular surgery, including procedures like Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) and coronary artery bypass grafting (CABG).

Moreover, traditional surgical techniques involve the use of autologous vessels, such as saphenous veins and internal thoracic arteries, or prosthetic grafts, including polyester vascular grafts and hybrid vascular guts.  However, the limitations of these options, particularly in terms of blood clot formation and suitability for complex vascular procedures, have led to the development of Tissue Engineered Vascular Grafts (TEVGs). Thus, such trends will shape the growth of the market during the forecast period.

Major Market Challenge

Risks and complications associated with vascular grafting is the major challenge that affects the growth of the market. Vascular grafts are essential in surgical interventions such as the Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) procedure, where they are used to bypass occluded or narrowed coronary arteries.

However, complications related to vascular grafts can significantly impact long-term mortality and morbidity rates. These complications include infected grafts, pseudoaneurysms, and aortoenteric fistulas. Although rare, these complications can be life-threatening if they occur. Infections are the most common complications, which can lead to graft thrombosis, hemorrhage, and overwhelming sepsis ischemia. Hence, the above factors will impede the growth of the market during the forecast period.

Exculsive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories: The company offers vascular grafts such as GRAFTMASTER RX Coronary Stent Graft System.

The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Artivion Inc.
• Aruga Technologies
• B.Braun SE
• Becton Dickinson and Co.
• Bentley InnoMed GmbH
• BIOTRONIK SE and Co. KG
• BIOVIC Sdn Bhd
• Cardinal Health Inc.
• Cook Group Inc.
• Endologix LLC
• Getinge AB
• Heart Medical Europe BV
• InnAVasc Medical Inc.
• Japan Lifeline Co. Ltd.
• LeMaitre Vascular Inc.
• Lombard Medical Ltd.
• Medtronic Plc
• MicroPort Scientific Corp.
• Terumo Corp.
• Vascular Graft Solutions Ltd.
• W. L. Gore and Associates Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Segmentation

By Product 

The endovascular grafts segment is estimated to witness significant growth during the forecast period. The market encompasses the production and distribution of artificial blood vessels used to replace diseased arteries in various surgical procedures. Abdominal aneurysms, a common vascular condition affecting the geriatric population and often linked to smoking, are a significant driver for this market. Vascular grafts are essential for procedures such as endovascular aneurysm repair and hemodialysis vascular access.

Get a glance at the market share of various regions Download the PDF Sample

The endovascular grafts segment was the largest segment and valued at USD 1.53 billion in 2018. Raw materials used in the production of vascular grafts include polyester, PTFE, and polyurethane. Hospitals and cardiac centers are the primary end-users of vascular grafts, with healthcare reforms and increasing chronic diseases, such as diabetes and heart attacks, fueling demand. Government funding and reimbursement schemes play a crucial role in market growth, particularly in emerging economies. Hence, such factors are fuelling the growth of this segment during the forecast period.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The market encompasses the production and distribution of artificial blood vessels used to replace diseased arteries in various surgical procedures. Abdominal aneurysms, a common condition affecting the geriatric population and often exacerbated by smoking, are a primary application for vascular grafts. These grafts facilitate the restoration of blood flow and prevent complications such as rupture. Raw materials, including polyester grafts, PTFE, and polyurethane, are utilized in the manufacturing process. Vascular grafts find extensive use in hemodialysis vascular access, endovascular aneurysm repair, and cardiac centers. Healthcare reforms and increasing chronic diseases, such as diabetes and heart attacks, fuel market growth during the forecast period.

Segment Overview

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• Product Outlook
  • Endovascular grafts
  • Bypass grafts
  • Hemodialysis grafts
  • Peripheral grafts
• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • APAC
    • China
    • India
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa

You may also interested in below market reports:

•  Aortic Stent Grafts Market: Aortic Stent Grafts Market by Application and Geography - Forecast and Analysis
• Endovascular Abdominal Aortic Aneurysm (AAA) Repair Devices Market: Endovascular Abdominal Aortic Aneurysm (AAA) Repair Devices Market by End-user, Product, and Geography - Forecast and Analysis
• Fractional Flow Reserve Devices Market: Global Fractional Flow Reserve Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Japan, Canada - Size and Forecast

Market Analyst Overview

The Market refers to the global industry dedicated to producing and supplying vascular grafts for various medical applications. Vascular grafts are synthetic or biological substitutes used to replace damaged or diseased arteries or veins. They are commonly used in surgical procedures for Abdominal aneurysms, hemodialysis vascular access, and Endovascular aneurysm repair. Key factors driving the market growth include the increasing prevalence of chronic diseases such as Geriatric population, Diabetes, and Smoking, which contribute to Vascular diseases like Abdominal aneurysms, Heart attacks, and Vascular obstacles. Additionally, the rise in healthcare expenditure due to Government funding and healthcare reforms in Emerging economies is expected to fuel market growth.

Moreover, raw materials used in manufacturing vascular grafts include Polyester grafts, Polyurethane, PTFE, and Biomaterial grafts. The market caters to various end-users, including Hospitals, Cardiac centers, and Dialysis centers. The market landscape depends on the End stage renal disease, Polyester vascular graft, Peripheral artery disease (PAD), Coronary artery disease (CAD), Chronic kidney disease (CKD), Constructive graft remodelling, Aortic cross clamp, Coronary artery stent grafts, Electrospun polyurethane vascular grafts, MDPI, Self cleaning vascular grafts, Cutting edge grafts, Synthetic vascular grafts, Hybrid vascular grafts, Peripheral vascular grafts, Cardiac aneurysm, Vascular occlusion. Technological advancements in minimally invasive procedures, such as Endovascular stent grafts, have led to constructive graft remodeling and reduced Intimal hyperplasia and Thrombosis. The market is also influenced by factors like Reimbursement schemes, Chronic diseases, and Corona virus infections. Hemodialysis, a common application of vascular grafts, is used for Kidney transplantation and Hemodialysis treatment. The market is expected to witness significant growth due to the increasing number of surgical procedures and the rising demand for advanced vascular grafts.

Download PDF Sample

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2023 and 2028
• Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies